A Study of Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard Treatment

​ Conditions: Aplastic Anemia

Interventions: Drug: Avatrombopag 20 mg Oral Tablet

Sponsors: Swedish Orphan Biovitrum; Sobi, Inc.; CMIC Co, Ltd. Japan

Not yet recruiting Conditions: Aplastic Anemia
Interventions: Drug: Avatrombopag 20 mg Oral Tablet
Sponsors: Swedish Orphan Biovitrum; Sobi, Inc.; CMIC Co, Ltd. Japan
Not yet recruiting